⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Stanislaus OroweM.D.

Internal Medicine · Southfield, MI 48075

NPI: 1144370479

Share:

36

🟠 Elevated

🤖 ML Fraud Detection Score: 93%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Very high opioid rate vs specialty peersOpioid + benzodiazepine co-prescriberExtreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

11,454

Total Claims

$500K

Drug Cost

318

Beneficiaries

$1,573

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Opioid + benzodiazepine combo+8
High fills per patient+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+682%

Opioid rate vs peers

17.5% vs 2.2% avg

+11%

Cost per patient vs peers

$1,573 vs $1,411 avg

-16%

Brand preference vs peers

8.9% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

🤖

ML fraud detection score of 93% indicates prescribing patterns with significant similarity to confirmed fraud cases. 19 out of 20 decision trees flagged this provider.

⚠️

Opioid prescribing rate is 682% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

17.5%

Opioid Rate

2,005

Opioid Claims

$64K

Opioid Cost

1.9%

Long-Acting Rate

Brand vs Generic

91% generic

Brand: 1,015 claims · $295K

Generic: 10,379 claims · $202K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Budesonide/Formoterol Fumarate67$27K
Apixaban42$26K
Sitagliptin Phosphate35$24K
Fluticasone Propion/Salmeterol51$22K
Hydrocodone/Acetaminophen846$21K
Linagliptin31$17K
Insulin Glargine,hum.Rec.Anlog35$16K
Fluticasone/Vilanterol36$15K
Oxymorphone Hcl22$15K
Tiotropium Bromide26$15K
Linaclotide21$12K
Albuterol Sulfate202$12K
Albuterol Sulfate302$11K
Oxycodone Hcl629$11K
Insulin Aspart15$8,795

Prescribing Profile

113

Unique Drugs

$60K

IRA Negotiated Drugs

36.0

Anomaly Score

Patient Profile

63

Avg Age

61%

Female

2.04

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About